Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis?

Tytuł :
Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis?
Autorzy :
Petitpain, Nadine
Devos, David
Bagheri, Haleh
Rocher, Fanny
Gouraud, Aurore
Masmoudi, Kamel
Coquerel, Antoine
Pokaż więcej
Temat :
AMYOTROPHIC lateral sclerosis
RISK exposure
DISEASE risk factors
HERBICIDE resistance
RHEUMATISM
Źródło :
Fundamental & Clinical Pharmacology; Dec2019, Vol. 33 Issue 6, p689-694, 6p
Czasopismo naukowe
TNFα modulation has been reported to be either beneficial or detrimental in amyotrophic lateral sclerosis (ALS) and therefore appears as a key issue. We analysed the relationship between TNFα inhibitor (TNFi) exposure and ALS. We performed descriptive analysis of ALS reports in patients treated with TNFi, registered in the French Pharmacovigilance Database (FPvD) and disproportionality analyses by the 'case'/'non‐case' method in FPvD and worldwide database (Vigibase®). The 8 retrieved ALS cases from the FPvD were 5 with limb‐onset and 3 with bulbar‐onset forms, in patients aged 43–75 years old, mainly treated for inflammatory rheumatism. The time to onset of the first symptoms ranged from 12 to 108 months, and the cumulative TNFi exposure before the diagnosis ranged from 12 to 120 months. TNFi was discontinued and thereafter survival ranged between 12 and 20 months. Disproportionality analyses showed significant associations between TNFi exposure and ALS in the FPvD and Vigibase® (160 ALS cases), regardless comparators. A putative association between TNFi and ALS must be interpreted cautiously, but TNFi could act as a predisposing or risk factor. TNFi should therefore be avoided in patients with a known risk of ALS and discontinued in the case of neurological signs of ALS. [ABSTRACT FROM AUTHOR]
Copyright of Fundamental & Clinical Pharmacology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies